Literature DB >> 15155508

Primary angioplasty should be first line treatment for acute myocardial infarction: FOR.

David Smith1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15155508      PMCID： PMC416609          DOI： 10.1136/bmj.328.7450.1254

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction.

Authors:  E García; J Elízaga; N Pérez-Castellano; J A Serrano; J Soriano; M Abeytua; J Botas; R Rubio; E López de Sá; J L López-Sendón; J L Delcán
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

2.  Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.

Authors:  C M Gibson; C P Cannon; S A Murphy; K A Ryan; R Mesley; S J Marble; C H McCabe; F Van De Werf; E Braunwald
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

3.  Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction.

Authors:  C L Grines; D L Marsalese; B Brodie; J Griffin; B Donohue; C R Costantini; C Balestrini; G Stone; T Wharton; P Esente; M Spain; J Moses; M Nobuyoshi; M Ayres; D Jones; D Mason; D Sachs; L L Grines; W O'Neill
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

4.  Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks.

Authors:  J K French; T A Hyde; H Patel; D J Amos; S C McLaughlin; B J Webber; H D White
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

5.  Significance of the Thrombolysis in Myocardial Infarction scoring system in assessing infarct-related artery reperfusion and mortality rates after acute myocardial infarction.

Authors:  F Fath-Ordoubadi; T Y Huehns; A Al-Mohammad; K J Beatt
Journal:  Am Heart J       Date:  1997-07       Impact factor: 4.749

6.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

7.  A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.

Authors:  C L Grines; K F Browne; J Marco; D Rothbaum; G W Stone; J O'Keefe; P Overlie; B Donohue; N Chelliah; G C Timmis
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

Review 9.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321
  9 in total
  4 in total

1.  Reduce door to needle, not door to balloon, times first.

Authors:  Sharif Hossain
Journal:  BMJ       Date:  2004-06-26

2.  Reducing mortality in myocardial infarction.

Authors:  Jonathan N Townend; Sagar N Doshi
Journal:  BMJ       Date:  2005-04-16

Review 3.  Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis.

Authors:  Christian Asseburg; Yolanda Bravo Vergel; Stephen Palmer; Elisabeth Fenwick; Mark de Belder; Keith R Abrams; Mark Sculpher
Journal:  Heart       Date:  2007-02-03       Impact factor: 5.994

Review 4.  Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis.

Authors:  Yolanda Bravo Vergel; Stephen Palmer; Christian Asseburg; Elisabeth Fenwick; Mark de Belder; Keith Abrams; Mark Sculpher
Journal:  Heart       Date:  2007-08-23       Impact factor: 5.994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.